Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

BetaPharma

BetaPharma
1996 FOUNDED
PRIVATE STATUS
21-30 EMPLOYEES
Debt Repay. LATEST DEAL TYPE
3 FINANCING ROUNDS
Description

Developer of pharmaceutical products related to oncology. The company specializes in developing late stage therapies targeting oncology, pharmaceuticals, drug discovery and has a major product Icotinib.

Formerly Known As
Beta Chemicals
Ownership Status
Privately Held (backing)
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Other Pharmaceuticals and Biotechnology
Primary Office
  • 5 Vaughn Drive
  • Suite 106
  • Princeton, NJ 08540
  • United States

+1 (609) 000-0000

BetaPharma Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore BetaPharma‘s full profile, request access.

Request full access to PitchBook

BetaPharma Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Tris Pharma Private Debt Financed Monmouth Junction, NJ 000 000000000 00
00000000 Formerly VC-backed Dublin, Ireland 0000 00.000 000000000 00.000
00000000 Corporate Backed or Acquired Dublin, Ireland 0000 000000&0
0000000 0000000000 Corporate Backed or Acquired Hauppauge, NY 000 000000&0
000000 00000000000 Formerly VC-backed Westlake Village, CA 00 00000 0000000000.
To view this company’s complete list of competitors, request access »

BetaPharma Executive Team (3)

Name Title Board
Seat
Contact
Info
Don Zhang Ph.D Chief Executive Officer, President & Founder
Jirong Peng Ph.D Vice President & Chief Operating Officer
Michael Greco VP of Research and Development & Chief Scientific Officer